フルテキストファイル
著者
Teraoka, Shogo Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University
Honda, Masashi Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Shimizu, Ryutaro Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University
Nishikawa, Ryoma Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧
Kimura, Yusuke Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧
Yumioka, Tetsuya Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧
Iwamoto, Hideto Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Morizane, Shuichi Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Hikita, Katsuya Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
Takenaka, Atsushi Division of Urology, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University 研究者総覧 KAKEN
キーワード
Image-guided biopsy
magnetic resonance imaging
prostate
prostatic neoplasms
ultrasonography
抄録
[Background] In recent years, the effectiveness of magnetic resonance imaging (MRI)-ultrasound fusion targeted biopsy (MRF-TB) has been widely reported. In this study, we assessed the effect of reduction of the number of systematic biopsy (SB) cores on the cancer detection rate (CDR). [Methods] Patients with a high prostate-specific antigen (PSA) level underwent prostate MRI. The Prostate Imaging-Reporting and Data System version 2 (PI-RADS) was then used to rate the lesions. The inclusion criteria were as follows: (1) PSA level between 4.0 and 30.0 ng/mL and (2) patients with one or more lesions on MRI and a PI-RADS score of 3 or more. All enrolled patients were SB naïve or had a history of one or more prior negative SBs. A total of 104 Japanese met this selection criterion. We have traditionally performed 14-core SB following the MRF-TB. In this study, the CDRs of 10-core SB methods, excluding biopsy results at the center of the base and mid-level on both sides, were compared with those of the conventional biopsy method. [Results] We compared CDRs of the 14-core and 10-core SBs used in combination. The overall CDR was 55.8% for the former and 55.8% for the latter, thereby indicating that there was no significant difference (P = 1.00) between the two. In addition, the CDRs of csPCa were 51.9% for the former and 51.1% for the latter, which indicated that there was no significant difference (P = 0.317). [Conclusion] There was no significant difference in the CDR when the number of SB cores to be used in combination was 14 and 10.
出版者
Tottori University Medical Press
資料タイプ
学術雑誌論文
外部リンク
ISSN
05135710
EISSN
13468049
書誌ID
AA00892882
掲載誌名
Yonago Acta Medica
最新掲載誌名
Yonago Acta Medica
64
3
開始ページ
260
終了ページ
268
発行日
2021-08-24
出版者DOI
著者版フラグ
出版社版
著作権表記
(C) 2021 Tottori University Medical Press
掲載情報
Teraoka Shogo, Honda Masashi, Shimizu Ryutaro, et al. Optimal Number of Systematic Biopsy Cores Used in Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Targeted Prostate Biopsy. Yonago Acta Medica. 2021, 64(3), 260-268. doi:10.33160/yam.2021.08.004
部局名
医学部・医学系研究科・医学部附属病院
言語
英語